checkAd
    Startseite > Aktien > Pharvaris > Nachrichten
    Pharvaris Aktie
    21,000
     
    EUR
    -0,94 %
    -0,200 EUR
    Letzter Kurs 06.05.24 Tradegate
    20,800
     
    EUR
    97 STK
    Geldkurs 09:31:28
    21,400
     
    EUR
    94 STK
    Briefkurs 09:31:28
    ISIN: NL00150005Y4 · WKN: A2QNWS · SYM: 9EN · Niederlande

    Neueste Nachrichten

    Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    10.04.24 · globenewswire · Pharvaris
    Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer
    10.04.24 · globenewswire · Pharvaris
    Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference
    04.04.24 · globenewswire · Pharvaris
    Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses
    18.03.24 · globenewswire · Pharvaris
    Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses
    06.03.24 · globenewswire · Pharvaris
    Pharvaris to Participate in the Leerink Global Biopharma Conference 2024
    05.03.24 · globenewswire · Pharvaris
    Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting
    22.02.24 · globenewswire · Pharvaris
    Pharvaris Announces Extraordinary Meeting of Shareholders
    16.02.24 · globenewswire · Pharvaris
    Pharvaris to Present at the WSAAI Annual Meeting 2024
    26.01.24 · globenewswire · Pharvaris
    Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks
    22.01.24 · globenewswire · Pharvaris
    Pharvaris Provides Business Update and Outlines 2024 Strategic Priorities
    05.01.24 · globenewswire · Pharvaris
    Pharvaris to Present at the GA²LEN UCARE Conference 2023
    30.11.23 · globenewswire · Pharvaris